Celltrion Healthcare Co.
Scope
Date
~
-
Bio & Pharma
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Mar 14, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hahn & Co. puts SK Shipping’s tanker business up for sale
South Korean private equity firm Hahn & Co. is seeking to sell SK Shipping Co.’s tanker division, a business widely seen as the breadwinne...
Mar 13, 2023 (Gmt+09:00)
-
Upcoming IPOs
Korea’s sole foreign clinic operator CHA Healthcare to go public in 2025
CHA Healthcare Co. operating nearly 90 hospitals and infertility treatment centers across the world, is set to pave the way for South Koreans' inves...
Mar 08, 2023 (Gmt+09:00)
-
Automobiles
Hankook & Co. buys autonomous driving tech startup 3Secondz
Hankook & Company Co., a South Korean holding company that owns tire and mobility businesses, said on Tuesday that it has acquired the autonomou...
Mar 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Healthcare
Kakao Healthcare to launch diabetes monitoring app
South Korea’s dominant mobile platform Kakao Corp. will kick off its healthcare services this year with the launch of a diabetes monitoring ap...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Feb 16, 2023 (Gmt+09:00)
-
Healthcare
Daesang Wellife signs contract with RexSoft for healthcare platform
South Korea's Daesang Wellife Corp. has inked a 2 billion won ($1.5 million) investment contract with local healthcare data science company RexSoft ...
Feb 15, 2023 (Gmt+09:00)
-
Steel
Hyundai Steel co-hosts symposium on low-carbon construction materials
Hyundai Steel has joined hands with the construction industry to increase the recycling of steel byproducts.On Tuesday, the steel maker organized a ...
Feb 15, 2023 (Gmt+09:00)
-
Artificial intelligence
S.Korea's Lunit supplies breast cancer imaging solution to UAE
South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to...
Feb 09, 2023 (Gmt+09:00)
-
Cryptocurrencies
Binance acquires majority stake in S.Korea's crypto exchange Gopax
Binance, the leading cryptocurrency exchange globally, has acquired a majority stake in South Korea's Gopax by purchasing CEO Lee Joon-haeng's 41.2%...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean biotech firms tap Middle East as next key market
South Korean biotech companies are speeding up their foray into the Middle East to tap oil money as they seek new growth engines beyond fossil fuels...
Feb 06, 2023 (Gmt+09:00)
-
Healthcare
SK C&C joins hands with Microsoft for digital healthcare solutions
SK C&C, an IT services unit of SK Group, said on Thursday that it had signed an agreement with Microsoft Korea to advance into the global market...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion increases its stake in British ADC developer Iksuda
Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Inc. eyes significant growth in bio business from 2024
SAN FRANCISCO – SK Inc., the investment and holding company of South Korea’s SK Group, expects significant growth in its biopharma...
Jan 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare lands biosimilar deal in Brazil for 2nd straight year
South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Korean startups
Korean law firm creates startup investment association
The Law Office of Choi & Lee, a small-sized law firm, became Korea's first law firm to invest in startups. In one of the most difficult times wh...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Korean startups
Samsung to unveil C-Lab startups, projects at CES 2023
Samsung Electronics Co. will showcase four projects and eight startups developed through its venture program C-Lab at CES 2023, the world's largest ...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Business & Politics
Doosan Enerbility to introduce ammonia co-fired power plant in Vietnam
Doosan Enerbility Co. plans to introduce an ammonia co-fired power plant in Vietnam jointly with South Korean and Vietnamese research institutes.Sou...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Food & Beverage
Korean confectionery and snack co. Orion enjoys brisk sales in Vietnam
South Korea’s confectionery and snack maker Orion Corp. is enjoying rapid growth in Vietnam, thanks to brisk sales of the Choco-Pie, a chocola...
Dec 22, 2022 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported car market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google